1Raju TN, Higgins RD, Stark AR, et al. Optimizing care and out-come for late-preterm (near-term) infants: a summary of the work-shop sponsored by the National Institute of Child Health and Human Development. Pediatrics,2006,118(3) :1207 - 1214.
2Rau GA, Vieten G, Haitsma JJ, et al. Surfactant in newborn compared with adolescent pigs: adaptation to neonatal respiration. Am J Respir Cell Mol Biol,2004 ,30 ( 5 ) : 694 - 701.
3RICHARD G, LYNCH M. D. Surfactant and RDS in premature infants. The FASEB Journal, 2004,18 : 1624.
4Kattwinkel J. Synthetic surfactants: the search goes on. Pediatrics, 2005 , 115 (4) : 1075 - 1076.
5Moya F, Sinha S, Gadzinowski J, et al. One-Year Follow-up of Very Preterm Infants Who Received Lucinactant for Prevention of Respiratory Distress Syndrome: Results From 2 Muhicenter Randomized, Controlled Trials. Pediatrics, 2007 , 119 ( 6 ) : e1361 - 1370.
6Sinha SK, Lacaze-Masmonteil T, Vails i Soler A, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics, 2005 , 115 (4) : 1030 - 1038.
